Literature DB >> 30187278

Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.

Leonard Angka1,2, Andre B Martel1,3, Marisa Kilgour4, Ahwon Jeong1, Manahil Sadiq1, Christiano Tanese de Souza1, Laura Baker1,3, Michael A Kennedy1, Natasha Kekre1,2,5, Rebecca C Auer6,7,8.   

Abstract

BACKGROUND: Surgical stress results in a significant reduction in natural killer (NK) cell cytotoxicity (NKC), which has been linked to postoperative cancer metastases. However, few studies have measured the impact of surgical stress upon NK cell IFNγ secretion (NKA), a cytokine with essential roles in controlling infection and metastases. The objective of this study was to investigate the impact of surgical stress on NKA in colorectal cancer (CRC) surgery patients.
METHODS: Peripheral blood was collected from CRC surgery patients (n = 42) preoperatively and on postoperative day (POD) 1, 3, 5, 28, and 56. Healthy donor blood (n = 27) was collected for controls. We assessed NKA by production of IFNγ following whole blood cytokine stimulation, NKC by 51Cr-release assay, and immune cell profiling by flow cytometry.
RESULTS: The mean reduction in NKA on POD1 compared with baseline was 83.1% (standard deviation 25.2%; confidence interval 75-91), and therefore the study met the primary endpoint of demonstrating a > 75% decrease in a cohort of CRC surgery patients (p < 0.0001). The profound and universal suppression of NKA persisted with 65.5% (19/29) and 33.3% (4/12) of patients with levels measuring < 75% of baseline on POD28 and POD56 respectively. The NKC was significantly reduced on POD1, but the degree was less pronounced (24.6%, p = 0.0024). Immune cell profiling did not reveal differences in the absolute number of NK cells (CD3-CD56+) or the ratio of CD56dim-to-CD56bright subsets.
CONCLUSIONS: NKA is significantly suppressed for up to two months following surgery in CRC patients, a degree of surgery-induced immunosuppression far worse than previously reported.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30187278     DOI: 10.1245/s10434-018-6691-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  23 in total

Review 1.  Killers 2.0: NK cell therapies at the forefront of cancer control.

Authors:  Jonathan J Hodgins; Sarwat T Khan; Maria M Park; Rebecca C Auer; Michele Ardolino
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

Review 2.  Is innate immunity our best weapon for flattening the curve?

Authors:  Leonard Angka; Marisa Market; Michele Ardolino; Rebecca C Auer
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

3.  A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients.

Authors:  Leonard Angka; Andre B Martel; Juliana Ng; Amanda Pecarskie; Manahil Sadiq; Ahwon Jeong; Marlena Scaffidi; Christiano Tanese de Souza; Michael A Kennedy; Shaheer Tadros; Rebecca C Auer
Journal:  Ann Surg Oncol       Date:  2022-07-25       Impact factor: 4.339

4.  Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgery.

Authors:  Leonard Angka; Christiano Tanese de Souza; Katherine E Baxter; Sarwat T Khan; Marisa Market; Andre B Martel; Lee-Hwa Tai; Michael A Kennedy; John C Bell; Rebecca C Auer
Journal:  Mol Ther       Date:  2022-05-26       Impact factor: 12.910

Review 5.  Tumor regionalization after surgery: Roles of the tumor microenvironment and neutrophil extracellular traps.

Authors:  Su-Bin Kwak; Sang Jin Kim; Jiyoung Kim; Ye-Lim Kang; Chang Woo Ko; Iljin Kim; Jong-Wan Park
Journal:  Exp Mol Med       Date:  2022-06-28       Impact factor: 12.153

Review 6.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

Review 7.  Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies.

Authors:  Fan Tang; Yan Tie; Chongqi Tu; Xiawei Wei
Journal:  Clin Transl Med       Date:  2020-01

Review 8.  Surgical stress and cancer progression: the twisted tango.

Authors:  Zhiwei Chen; Peidong Zhang; Ya Xu; Jiahui Yan; Zixuan Liu; Wayne Bond Lau; Bonnie Lau; Ying Li; Xia Zhao; Yuquan Wei; Shengtao Zhou
Journal:  Mol Cancer       Date:  2019-09-02       Impact factor: 27.401

Review 9.  Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.

Authors:  Marisa Market; Leonard Angka; Andre B Martel; Donald Bastin; Oladunni Olanubi; Gayashan Tennakoon; Dominique M Boucher; Juliana Ng; Michele Ardolino; Rebecca C Auer
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

Review 10.  Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.

Authors:  Bilikis Aderonke Abolarinwa; Ridwan Babatunde Ibrahim; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.